Nelson v. Wyeth LLC, 4:10-cv-00764

MDL 1507 designated a centralized forum for hormone therapy product liability cases, with January 2005 transfer to MDL and later remand decisions.
Arizona multi-plaintiff case 4:05-CV-0077-WRW was remanded to District of Arizona for case-specific proceedings.
Judge Wilson ordered remand with all but the first-named plaintiff dropped, allowing new individual complaints with relation-back for time-bar analyses.
By March 24, 2011, 43 remanded Arizona cases across multiple divisions and judges awaited pretrial coordination or case-specific discovery.
Wyeth and Pfizer moved to transfer remanded cases for pretrial coordination to the undersigned judge, citing judicial economy.
Lazell opposed transfer, arguing seven years of MDL coordination already exhausted and additional delays with minimal benefit.

Issue	Plaintiff's Argument	Defendant's Argument	Held
Whether to transfer remanded cases for pretrial coordination	Lazell: no benefit, causes delay after MDL efforts	Wyeth/Pfizer: consolidate to improve discovery planning and avoid duplication	Denied; cases proceed individually
Whether common issues justify centralized coordination	No need; discovery advanced and time for case-specific issues remains	Common issues exist; coordination would streamline briefing	Not sufficient to warrant transfer
Impact on case-specific discovery and trial scheduling	Further coordination delays trials and drains court resources	Coordinated discovery benefits all by uniform planning	Each case should proceed on its own terms

In re Prempro Products Liability Litigation, 586 F.3d 547 (8th Cir. 2009) (accrual and discovery timing considerations informed by analogous products-liability context)
Logerquist v. Danforth, 188 Ariz. 16 (Ariz. Ct. App. 1996) (Arizona discovery-rule accrual standards for product liability actions)
Gust, Rosenfeld & Henderson v. Prudential Ins. Co., 182 Ariz. 586 (Ct. App. 1995) (discovery-rule rationale motivating accrual timing)